Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
How does GHK-Cu compare to BPC-157 for tissue repair research
Published human trials report mild gastrointestinal discomfort in 814% of participants and transient headache in 57%, with symptoms typically resolving within 23 weeks
Most clinical and research GHK-Cu protocols sit at 0.52 mg per day subcutaneously, and many patients do not inject every day - 23 injections per week is common for skin and maintenance goals
Enter your own vial size and water volume in the calculator to get the draw volume for the dose your provider prescribed
and omega-3 fatty acids, which are associated with slower telomere attrition via anti-inflammatory and antioxidant effects
A mouse study using 15 mg/kg/day doesnt translate directly to safe and effective human dosing
